4GH9

Crystal structure of Marburg virus VP35 RNA binding domain

Summary for 4GH9

• Entry DOI: 10.2210/pdb4gh9/pdb
• Related: 3FKE 3KS8 3L25 3L26 3L2A 4GHA
• Descriptor: Polymerase cofactor VP35, ACETATE ION (3 entities in total)
• Functional Keywords: viral polymerase, interferon inhibition, double stranded viral rna, viral protein, rna binding protein
• Biological source: Marburg virus (MARV)
• Cellular location: Virion: P35259
• Total number of polymer chains: 1
• Total formula weight: 16656.87

Authors

Bale, S.,Jean-Philippe, J.,Bornholdt, Z.A.,Kimberlin, C.K.,Halfmann, P.,Zandonatti, M.A.,Kunert, J.,Kroon, G.J.A.,Kawaoka, Y.,MacRae, I.J.,Wilson, I.A.,Saphire, E.O. (deposition date: 2012-08-07, release date: 2012-08-15, Last modification date: 2023-09-13)

Primary citation

Bale, S.,Julien, J.P.,Bornholdt, Z.A.,Kimberlin, C.R.,Halfmann, P.,Zandonatti, M.A.,Kunert, J.,Kroon, G.J.,Kawaoka, Y.,Macrae, I.J.,Wilson, I.A.,Saphire, E.O.
Marburg Virus VP35 Can Both Fully Coat the Backbone and Cap the Ends of dsRNA for Interferon Antagonism.
Plos Pathog., 8:e1002916-e1002916, 2012

PubMed Abstract: Filoviruses, including Marburg virus (MARV) and Ebola virus (EBOV), cause fatal hemorrhagic fever in humans and non-human primates. All filoviruses encode a unique multi-functional protein termed VP35. The C-terminal double-stranded (ds)RNA-binding domain (RBD) of VP35 has been implicated in interferon antagonism and immune evasion. Crystal structures of the VP35 RBD from two ebolaviruses have previously demonstrated that the viral protein caps the ends of dsRNA. However, it is not yet understood how the expanses of dsRNA backbone, between the ends, are masked from immune surveillance during filovirus infection. Here, we report the crystal structure of MARV VP35 RBD bound to dsRNA. In the crystal structure, molecules of dsRNA stack end-to-end to form a pseudo-continuous oligonucleotide. This oligonucleotide is continuously and completely coated along its sugar-phosphate backbone by the MARV VP35 RBD. Analysis of dsRNA binding by dot-blot and isothermal titration calorimetry reveals that multiple copies of MARV VP35 RBD can indeed bind the dsRNA sugar-phosphate backbone in a cooperative manner in solution. Further, MARV VP35 RBD can also cap the ends of the dsRNA in solution, although this arrangement was not captured in crystals. Together, these studies suggest that MARV VP35 can both coat the backbone and cap the ends, and that for MARV, coating of the dsRNA backbone may be an essential mechanism by which dsRNA is masked from backbone-sensing immune surveillance molecules.

PubMed: 23028316
DOI: 10.1371/journal.ppat.1002916

Experimental method

X-RAY DIFFRACTION (1.65 Å)